349 related articles for article (PubMed ID: 29590640)
1. Intestinal epithelial cell polarity defects in disease: lessons from microvillus inclusion disease.
Schneeberger K; Roth S; Nieuwenhuis EES; Middendorp S
Dis Model Mech; 2018 Feb; 11(2):. PubMed ID: 29590640
[TBL] [Abstract][Full Text] [Related]
2. An inducible mouse model for microvillus inclusion disease reveals a role for myosin Vb in apical and basolateral trafficking.
Schneeberger K; Vogel GF; Teunissen H; van Ommen DD; Begthel H; El Bouazzaoui L; van Vugt AH; Beekman JM; Klumperman J; Müller T; Janecke A; Gerner P; Huber LA; Hess MW; Clevers H; van Es JH; Nieuwenhuis EE; Middendorp S
Proc Natl Acad Sci U S A; 2015 Oct; 112(40):12408-13. PubMed ID: 26392529
[TBL] [Abstract][Full Text] [Related]
3. Dynamic Formation of Microvillus Inclusions During Enterocyte Differentiation in
Mosa MH; Nicolle O; Maschalidi S; Sepulveda FE; Bidaud-Meynard A; Menche C; Michels BE; Michaux G; de Saint Basile G; Farin HF
Cell Mol Gastroenterol Hepatol; 2018; 6(4):477-493.e1. PubMed ID: 30364784
[TBL] [Abstract][Full Text] [Related]
4. The localisation of the apical Par/Cdc42 polarity module is specifically affected in microvillus inclusion disease.
Michaux G; Massey-Harroche D; Nicolle O; Rabant M; Brousse N; Goulet O; Le Bivic A; Ruemmele FM
Biol Cell; 2016 Jan; 108(1):19-28. PubMed ID: 26526116
[TBL] [Abstract][Full Text] [Related]
5. Loss of syntaxin 3 causes variant microvillus inclusion disease.
Wiegerinck CL; Janecke AR; Schneeberger K; Vogel GF; van Haaften-Visser DY; Escher JC; Adam R; Thöni CE; Pfaller K; Jordan AJ; Weis CA; Nijman IJ; Monroe GR; van Hasselt PM; Cutz E; Klumperman J; Clevers H; Nieuwenhuis EE; Houwen RH; van Haaften G; Hess MW; Huber LA; Stapelbroek JM; Müller T; Middendorp S
Gastroenterology; 2014 Jul; 147(1):65-68.e10. PubMed ID: 24726755
[TBL] [Abstract][Full Text] [Related]
6. Editing Myosin VB Gene to Create Porcine Model of Microvillus Inclusion Disease, With Microvillus-Lined Inclusions and Alterations in Sodium Transporters.
Engevik AC; Coutts AW; Kaji I; Rodriguez P; Ongaratto F; Saqui-Salces M; Medida RL; Meyer AR; Kolobova E; Engevik MA; Williams JA; Shub MD; Carlson DF; Melkamu T; Goldenring JR
Gastroenterology; 2020 Jun; 158(8):2236-2249.e9. PubMed ID: 32112796
[TBL] [Abstract][Full Text] [Related]
7. Myosin Vb uncoupling from RAB8A and RAB11A elicits microvillus inclusion disease.
Knowles BC; Roland JT; Krishnan M; Tyska MJ; Lapierre LA; Dickman PS; Goldenring JR; Shub MD
J Clin Invest; 2014 Jul; 124(7):2947-62. PubMed ID: 24892806
[TBL] [Abstract][Full Text] [Related]
8. Microvillus inclusion disease: loss of Myosin vb disrupts intracellular traffic and cell polarity.
Thoeni CE; Vogel GF; Tancevski I; Geley S; Lechner S; Pfaller K; Hess MW; Müller T; Janecke AR; Avitzur Y; Muise A; Cutz E; Huber LA
Traffic; 2014 Jan; 15(1):22-42. PubMed ID: 24138727
[TBL] [Abstract][Full Text] [Related]
9. The zebrafish goosepimples/myosin Vb mutant exhibits cellular attributes of human microvillus inclusion disease.
Sidhaye J; Pinto CS; Dharap S; Jacob T; Bhargava S; Sonawane M
Mech Dev; 2016 Nov; 142():62-74. PubMed ID: 27497746
[TBL] [Abstract][Full Text] [Related]
10. Bowel "dissection" in microvillus inclusion disease.
Chiang MC; Hsu JF; Hsueh C; Chao HC; Wang TH; Chen CP; Lai MW
Pediatr Neonatol; 2015 Apr; 56(2):129-31. PubMed ID: 23608388
[TBL] [Abstract][Full Text] [Related]
11. MYO5B mutations in patients with microvillus inclusion disease presenting with transient renal Fanconi syndrome.
Golachowska MR; van Dael CM; Keuning H; Karrenbeld A; Hoekstra D; Gijsbers CF; Benninga MA; Rings EH; van Ijzendoorn SC
J Pediatr Gastroenterol Nutr; 2012 Apr; 54(4):491-8. PubMed ID: 22441677
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in understanding and managing malabsorption: focus on microvillus inclusion disease.
Jayawardena D; Alrefai WA; Dudeja PK; Gill RK
F1000Res; 2019; 8():. PubMed ID: 31824659
[TBL] [Abstract][Full Text] [Related]
13. Myo5b knockout mice as a model of microvillus inclusion disease.
Cartón-García F; Overeem AW; Nieto R; Bazzocco S; Dopeso H; Macaya I; Bilic J; Landolfi S; Hernandez-Losa J; Schwartz S; Ramon y Cajal S; van Ijzendoorn SC; Arango D
Sci Rep; 2015 Jul; 5():12312. PubMed ID: 26201991
[TBL] [Abstract][Full Text] [Related]
14. Lysophosphatidic Acid Increases Maturation of Brush Borders and SGLT1 Activity in MYO5B-deficient Mice, a Model of Microvillus Inclusion Disease.
Kaji I; Roland JT; Watanabe M; Engevik AC; Goldstein AE; Hodges CA; Goldenring JR
Gastroenterology; 2020 Oct; 159(4):1390-1405.e20. PubMed ID: 32534933
[TBL] [Abstract][Full Text] [Related]
15. Uncovering the Relationship Between Genes and Phenotypes Beyond the Gut in Microvillus Inclusion Disease.
Sun M; Pylypenko O; Zhou Z; Xu M; Li Q; Houdusse A; van IJzendoorn SCD
Cell Mol Gastroenterol Hepatol; 2024; 17(6):983-1005. PubMed ID: 38307491
[TBL] [Abstract][Full Text] [Related]
16. Trafficking Ion Transporters to the Apical Membrane of Polarized Intestinal Enterocytes.
Engevik AC; Goldenring JR
Cold Spring Harb Perspect Biol; 2018 Jan; 10(1):. PubMed ID: 28264818
[TBL] [Abstract][Full Text] [Related]
17. Cell differentiation is disrupted by MYO5B loss through Wnt/Notch imbalance.
Kaji I; Roland JT; Rathan-Kumar S; Engevik AC; Burman A; Goldstein AE; Watanabe M; Goldenring JR
JCI Insight; 2021 Aug; 6(16):. PubMed ID: 34197342
[TBL] [Abstract][Full Text] [Related]
18. Myosin 5b loss of function leads to defects in polarized signaling: implication for microvillus inclusion disease pathogenesis and treatment.
Kravtsov D; Mashukova A; Forteza R; Rodriguez MM; Ameen NA; Salas PJ
Am J Physiol Gastrointest Liver Physiol; 2014 Nov; 307(10):G992-G1001. PubMed ID: 25258405
[TBL] [Abstract][Full Text] [Related]
19. The Rab8 GTPase regulates apical protein localization in intestinal cells.
Sato T; Mushiake S; Kato Y; Sato K; Sato M; Takeda N; Ozono K; Miki K; Kubo Y; Tsuji A; Harada R; Harada A
Nature; 2007 Jul; 448(7151):366-9. PubMed ID: 17597763
[TBL] [Abstract][Full Text] [Related]
20. Altered MYO5B Function Underlies Microvillus Inclusion Disease: Opportunities for Intervention at a Cellular Level.
Bowman DM; Kaji I; Goldenring JR
Cell Mol Gastroenterol Hepatol; 2022; 14(3):553-565. PubMed ID: 35660026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
